Adderall XR Cost in Mississippi 2026: Cash Price, Insurance, and Compounded Alternatives

What Is Adderall XR and Why Does Pricing Vary So Much in Mississippi?

Adderall XR is an extended-release oral capsule containing mixed amphetamine salts (MAS), a combination of amphetamine and dextroamphetamine in a 75/25 ratio of d- to l-amphetamine isomers. The FDA originally approved the extended-release formulation for ADHD treatment in adults and children as young as six years old, with narcolepsy as a secondary approved indication. Teva Pharmaceuticals holds one of the primary generic manufacturing agreements, and dozens of generic versions now compete on the market. [1]

The gap between the $260 list price and the $30 average retail cash price in Mississippi reflects a system in which pharmacy benefit managers, manufacturer rebates, discount card networks, and 340B pricing agreements all operate in parallel. Patients paying purely out of pocket without any discount card are exposed to the full list price, while patients using a GoodRx, NeedyMeds, or manufacturer coupon typically pay closer to the $30 figure. The difference is real and material for a state where the median household income sits below the national median.

ADHD itself is not rare. The CDC estimates that approximately 9.8% of children aged 3 to 17 years in the United States have received an ADHD diagnosis, and adult diagnosis rates have increased steadily since 2020. [2] Mississippi's rural geography means that many patients rely on a single retail chain pharmacy, giving them less opportunity to comparison-shop across competitors.

Because Adderall XR is a DEA Schedule II controlled substance, it cannot be called in or faxed to a pharmacy in most circumstances. Mississippi follows federal DEA rules requiring a written or electronic prescription for each 30-day supply. [3] That regulatory layer adds a practical cost: patients must maintain an active prescribing relationship, which typically means at least one office or telehealth visit every 30 days or every 90 days depending on the prescriber and the payer.

What Does Adderall XR Actually Cost in Mississippi in 2026?

The out-of-pocket cost in Mississippi in 2026 depends almost entirely on which payment pathway a patient uses. Without any discount, the cash price at a major retail chain such as CVS or Walmart may range from $180 to $260 for a 30-capsule supply of a 20 mg generic, depending on the dispensing pharmacy's acquisition cost and markup. [4]

With a GoodRx or similar third-party discount card, the same prescription drops to approximately $25 to $45 at most Mississippi zip codes. That $30 average figure is consistent with what patients report at pharmacies in Jackson, Gulfport, Hattiesburg, and Biloxi. Prices at independent pharmacies sometimes run slightly higher than chain pharmacies because the independents have less negotiating use with discount card networks.

Patients with private insurance in Mississippi typically pay a $10 to $50 copay for generic mixed amphetamine salts, depending on formulary tier. Adderall XR brand name is more often placed on Tier 3 or Tier 4, producing copays of $60 to $150 per month even with insurance. Switching to a generic formulation at the same dose almost always reduces that figure. The American Academy of Family Physicians recommends generic substitution as a first-line cost-reduction strategy for stimulant medications when the branded product is not medically necessary. [5]

Mississippi Adderall XR Cost Summary (2026)

| Payment Method | Estimated Monthly Cost | |---|---| | Cash (no discount), brand or generic | $180 to $260 | | GoodRx or discount card, generic | $25 to $45 | | Private insurance, generic (Tier 1-2) | $10 to $50 copay | | Private insurance, brand (Tier 3-4) | $60 to $150 copay | | Mississippi Medicaid | Not covered | | Compounded MAS via 503A pharmacy | Varies; may be $0 to $60 |

Does Mississippi Medicaid Cover Adderall XR?

Mississippi Medicaid does not cover Adderall XR as of mid-2025. The Mississippi Division of Medicaid publishes a Preferred Drug List (PDL) that governs outpatient pharmacy benefits for approximately 700,000 enrollees. Mixed amphetamine salts extended-release formulations are not listed as preferred agents on the current PDL, and prior authorization requests for brand Adderall XR have historically been denied. [6]

Mississippi Medicaid does cover certain other ADHD medications. Methylphenidate extended-release formulations (generic Concerta equivalents and Ritalin LA generics) appear on the PDL with preferred status in the stimulant category. Atomoxetine (generic Strattera) is also covered, though it requires prior authorization. Patients on Mississippi Medicaid who need a stimulant medication should ask their prescriber about methylphenidate-based options before assuming no covered path exists.

For patients who specifically require mixed amphetamine salts and have Medicaid coverage, the options narrow. A prescriber may attempt a prior authorization with documented failure of a preferred stimulant, but approval is not guaranteed. The Mississippi Division of Medicaid's clinical prior authorization criteria do not include a clear pathway for Adderall XR coverage when preferred stimulants have failed. [6]

This coverage gap is clinically meaningful. The landmark Multimodal Treatment Study of ADHD (MTA Study, N=579) published in Archives of General Psychiatry in 1999 demonstrated that carefully titrated stimulant medication produced significantly greater symptom reduction than behavioral therapy alone or community care, with an effect size of 0.8 for the medication management group at 14 months. [7] When a proven medication class is inaccessible due to cost or coverage, patients face real functional consequences.

Is Compounded Mixed Amphetamine Salts Legal in Mississippi?

Compounded mixed amphetamine salts from a licensed 503A pharmacy are legally permissible in Mississippi for individual patients with a valid prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound controlled substances, including Schedule II amphetamines, for specific patients under a prescriber's order, provided the compounding does not involve commercial-scale manufacturing. [8]

Mississippi State Board of Pharmacy regulations align with federal 503A requirements. A licensed Mississippi pharmacy that holds the appropriate DEA compounding registration may prepare mixed amphetamine salts capsules in a dose strength not commercially available, or for a patient with a documented allergy to a commercially available excipient. The key legal requirements are a valid patient-specific prescription, a DEA Schedule II compounding registration at the pharmacy, and compliance with USP Chapter 795 non-sterile compounding standards. [9]

Practically speaking, not every Mississippi pharmacy is set up to compound Schedule II stimulants. The state has fewer than 20 pharmacies currently offering compounded MAS as of mid-2025. Patients who access compounded MAS through a telehealth provider or specialty pharmacy may find that the drug cost is absorbed into the telehealth subscription or dispensing fee, which is why some sources cite an effective drug cost of $0 for compounded MAS. That figure reflects a bundled pricing model, not a free medication.

The FDA's current enforcement policy does not prohibit 503A pharmacies from compounding amphetamine salts for individual patients, but it does restrict 503B outsourcing facilities from bulk-producing Schedule II compounds for general distribution. [10] Patients should verify that their compounding pharmacy holds a current DEA Schedule II registration and is licensed in Mississippi before transferring a prescription.

Can You Get Adderall XR via Telehealth in Mississippi?

Telehealth prescribing of Adderall XR is currently permitted in Mississippi. The temporary DEA flexibilities introduced during the COVID-19 public health emergency allowed controlled substance prescribing via telemedicine without a prior in-person visit, and Mississippi's state telehealth laws have remained permissive through 2025. [11]

The DEA issued proposed rules in 2023 that would have restricted initial Schedule II prescribing via telemedicine, but following extensive public comment, the agency extended the telemedicine flexibilities through at least late 2025 pending a final rule. As of the publication date of this article, a Mississippi-licensed prescriber may conduct an initial ADHD evaluation via live audio-visual telehealth and prescribe Adderall XR or a generic equivalent electronically to a Mississippi pharmacy. [12]

Patients using telehealth for ADHD management in Mississippi should confirm two things before their first appointment. First, the prescriber must hold a valid DEA registration in Mississippi (not just their home state). Second, the pharmacy must be able to receive an electronic controlled substance prescription (EPCS), which is now required under Mississippi Board of Pharmacy rules for Schedule II drugs in most circumstances. [9]

HealthRX offers telehealth ADHD evaluations for Mississippi residents. A board-certified clinician conducts a structured diagnostic interview using DSM-5-TR criteria, reviews prior treatment history, and can issue an electronic Schedule II prescription to a Mississippi pharmacy within 24 to 48 hours of a completed evaluation visit.

Which Private Insurance Plans Cover Adderall XR in Mississippi?

Most large commercial insurers operating in Mississippi include generic mixed amphetamine salts on their formularies, typically at Tier 1 or Tier 2 with a $10 to $40 copay per 30-day supply. The major insurers with significant Mississippi enrollment include BlueCross BlueShield of Mississippi, Humana, Aetna, and UnitedHealthcare. Each maintains its own formulary, and tier placement can change at annual plan renewals. [13]

Brand-name Adderall XR (manufactured by Shire/Takeda) is placed on Tier 3 or Tier 4 at most Mississippi commercial plans, generating higher cost sharing. The practical guidance is to ask your pharmacist to verify the generic mixed amphetamine salts entry on your plan's formulary specifically, since "Adderall XR" by name may show as non-preferred while the generic equivalent is preferred.

Mississippi's state employee health plan (SEBS) covers generic mixed amphetamine salts at a $15 copay for a 30-day supply through network retail pharmacies as of the 2025 plan year. Members should confirm the 2026 formulary directly with the Mississippi State and School Employees Life and Health Insurance Plan, as benefit designs change annually.

ACA marketplace plans sold on HealthCare.gov for Mississippi coverage years 2025 and 2026 are required to include one stimulant medication at a preferred tier under the mental health parity provisions of the Mental Health Parity and Addiction Equity Act. However, that requirement specifies a stimulant class, not a specific molecule, so a plan may satisfy parity by covering only methylphenidate at preferred status while placing mixed amphetamine salts on a higher tier. [14]

What Are the Cheapest Ways to Get Adderall XR in Mississippi?

Four strategies consistently produce the lowest out-of-pocket cost for mixed amphetamine salts in Mississippi.

Discount card at a high-volume pharmacy. Applying a GoodRx Gold, RxSaver, or NeedyMeds discount card to a generic MAS prescription at a Walmart, Kroger, or Costco pharmacy in Mississippi typically produces a price between $25 and $40 per month. Costco pharmacy is available to non-members for prescription purchases under Mississippi and federal pharmacy access rules. [4]

Mail-order generic through your insurer. Many Mississippi commercial plans charge a lower copay for a 90-day mail-order supply than for three separate 30-day retail fills. A Tier 1 generic that costs $15 per 30-day fill at retail may cost $30 for a 90-day mail-order supply, saving $15 per quarter. Not all DEA Schedule II prescriptions qualify for mail-order dispensing, but Mississippi allows 90-day Schedule II prescriptions under specific circumstances that a prescriber can document. [3]

Prior authorization for medically necessary brand. If a patient experiences clinical failure or adverse effects from all available generic formulations (a documented phenomenon in some patients due to differences in inactive ingredients and bead-release kinetics), a prescriber can submit a prior authorization arguing medical necessity for brand Adderall XR. Approval rates vary by insurer, but a well-documented PA letter citing the FDA's bioequivalence data and patient-specific tolerance issues may reduce the copay to the generic tier. [1]

Compounded MAS from a licensed 503A pharmacy. For patients with a telehealth subscription that bundles the compounded medication cost, the effective out-of-pocket for the drug itself may be zero or near zero. This path requires confirming that the compounding pharmacy holds a Mississippi DEA Schedule II registration and that the prescriber has documented a clinical reason for compounding rather than dispensing a commercially available product. [8]

How Effective Is Adderall XR Compared to Alternatives?

Adderall XR's efficacy in ADHD is among the best-documented in all of psychiatry. The MTA Study (N=579 to 14 months) found that medication management with stimulants produced an effect size of approximately 0.8 on ADHD symptom composite scores, significantly outperforming behavioral therapy alone. [7] A 2018 Cochrane systematic review of amphetamine-based medications for ADHD in adults (27 randomized trials, N=5,765) found that mixed amphetamine salts produced a standardized mean difference of 0.49 (95% CI 0.40 to 0.58) in investigator-rated ADHD symptoms compared to placebo, with an acceptable tolerability profile at standard doses. [15]

Typical adult dosing begins at 20 mg once daily in the morning, with titration in 10 mg increments at weekly intervals up to a maximum of 60 mg per day for adults with ADHD, per the prescribing label. [1] The extended-release bead system delivers approximately 50% of the dose immediately and 50% over the following four to eight hours, providing coverage through the school or work day.

Common adverse effects include decreased appetite, insomnia, elevated heart rate, and mild blood pressure increases. The American Heart Association recommends baseline cardiovascular evaluation before initiating stimulant therapy in adults, particularly those with known cardiac risk factors, citing data from observational studies showing a small but measurable increase in mean systolic blood pressure of 2 to 4 mmHg. [16]

For patients in whom stimulants are contraindicated, including those with uncontrolled hypertension, certain cardiac arrhythmias, or a history of stimulant misuse, alternatives include atomoxetine (a non-stimulant norepinephrine reuptake inhibitor), viloxazine extended-release (approved 2021), and guanfacine extended-release (approved for pediatric ADHD and used off-label in adults). [17]

Mississippi-Specific Access Considerations

Mississippi's geography adds a layer of complexity that purely price-focused articles miss. Sixty-two of Mississippi's 82 counties are classified as rural by the U.S. Health Resources and Services Administration. [18] In rural counties, the nearest pharmacy may be 20 to 40 miles away, and that pharmacy may not stock every generic MAS strength. The 20 mg and 30 mg capsules are most reliably stocked; less common strengths such as 5 mg and 15 mg may require a 3 to 5 business day order.

Shortage considerations also apply. The 2022 to 2024 Adderall shortage, driven by manufacturing constraints at Teva and Amneal, left many Mississippi patients without medication for weeks at a time. The FDA declared the shortage resolved in late 2024, but regional supply fluctuations at smaller distributors serving rural Mississippi pharmacies have persisted into early 2025. [19] Patients are advised to contact their pharmacy 7 to 10 days before their prescription is due to verify stock before the refill date.

Telehealth prescribing addresses the geographic access problem directly. A patient in Booneville or Yazoo City can complete an ADHD evaluation with a Mississippi-licensed prescriber over video and have an electronic prescription transmitted to their nearest pharmacy without leaving home.

Prior Authorization Strategy for Mississippi Patients

Prior authorization (PA) for Adderall XR in Mississippi commercial plans typically requires documentation of three items: an ADHD diagnosis meeting DSM-5-TR criteria, the patient's age (PA criteria differ for patients younger than 18 versus adults), and prior trial of at least one preferred stimulant, usually a methylphenidate-based agent, at an adequate dose for at least 30 days. [5]

Prescribers who document the PA request with ADHD rating scale scores (Conners Adult ADHD Rating Scale or ADHD-RS-IV) are more likely to receive approval on the first submission than those who rely on narrative notes alone. The American Academy of Pediatrics 2019 ADHD Clinical Practice Guideline recommends formal rating scales as part of initial diagnosis and treatment monitoring, and payers accept these scores as objective evidence. [20]

If a PA is denied, the standard appeal process in Mississippi gives the prescriber 30 days to submit a written appeal with additional clinical documentation. The Mississippi Insurance Department supervises this process and requires insurers to issue a final appeal decision within 60 days of the written appeal submission. [21]